EPICS-14: Point of Care Influenzascreening and SARS-CoV-2 (COVID-19) testing in the Emergency Department

Not Applicable

• Conditions: J10; U07.1; Influenza due to identified seasonal influenza virus; COVID-19, virus identified

• Registration Number: DRKS00019207
• Lead Sponsor: Charité Universitätsmedizin Berlin; Notfall- und Akutmedizin (CVK, CCM)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-23
• Study Completion: 2020-04-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 828

Inclusion Criteria

All patients attending the Emergency Departments during the study period with any influenza symptom and fever (=38.0°C) will be eligible to participate in the study.
No exclusion criteria will be applied.

Exclusion Criteria

< 18 years of age

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. sick days of personnel<br>2. Proportion of patients treated with antibiotic and antiviral therapy<br>

Secondary Outcome Measures

Name	Time	Method
length of hospital stay, in-hospital mortality, proportion of patients tested, ICU admission, proportion of patients with a final diagnosis of influenza or pneumonia, proportion of secondary infections, Aspergillus infections, pneumococci infections, between presentation to the ED and antiviral/antibiotic treatment, time to disposition, admission/discharge rate, medical procedures, laboratory tests performed, transmission rate on other patients.<br>turn-around-time until test result is available.<br>Physician decision making (disposition, medical procedures, antiviral/antibiotic therapy, laboratory parameters).<br>